ROPEOK(SH:688619)2023-04-26 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥24,265,314.80, representing a year-on-year increase of 122.45%[2]. - The net profit attributable to shareholders was a loss of ¥17,196,764.48, with basic and diluted earnings per share both at -¥0.09[2][6]. - The total operating revenue for Q1 2023 was CNY 24,265,314.80, a significant increase from CNY 10,907,971.17 in Q1 2022, representing a growth of approximately 122.5%[17]. - The total operating costs for Q1 2023 amounted to CNY 55,850,215.14, up from CNY 34,056,232.92 in Q1 2022, indicating an increase of about 64.2%[18]. - The net loss for Q1 2023 was CNY 17,479,763.45, compared to a net loss of CNY 13,425,828.86 in Q1 2022, reflecting a deterioration in performance[18]. - The operating profit for Q1 2023 was reported at -CNY 22,666,777.17, worsening from -CNY 17,051,586.19 in the same period last year[18]. Cash Flow and Financial Position - The net cash flow from operating activities was a negative ¥61,634,705.92, indicating cash outflow during the reporting period[2][6]. - The cash flow statement for Q1 2023 indicates ongoing financial challenges, with net cash flows from operating activities remaining under scrutiny[20]. - In Q1 2023, the cash inflow from operating activities totaled $64,106,980.75, a decrease of 23.8% compared to $83,991,654.60 in Q1 2022[23]. - The cash outflow from operating activities was $125,741,686.67, down from $160,006,673.67 in the same period last year, resulting in a net cash flow from operating activities of -$61,634,705.92, an improvement from -$76,015,019.07[23]. - The company reported a net increase in cash and cash equivalents of $33,793,255.92 in Q1 2023, contrasting with a net decrease of -$522,297,333.82 in Q1 2022[24]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,959,695,679.77, down 2.05% from the end of the previous year[3]. - The total assets as of Q1 2023 were CNY 1,959,695,679.77, a decrease from CNY 2,000,776,933.90 at the end of the previous period[15]. - The total liabilities for Q1 2023 were CNY 671,923,860.24, down from CNY 695,525,350.92 in the previous period[15]. - The total equity attributable to shareholders was CNY 1,270,179,685.28, slightly decreasing from CNY 1,287,376,449.76 in the previous period[15]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,997[7]. - The largest shareholder, Chen Yanxing, holds 37.73% of the shares, totaling 70,801,353 shares[8]. - The top five shareholders include Beijing Teda Borui Investment Management Co., Ltd. with 3,972,212 shares, representing 2.12% of total shares[10]. Research and Development - Research and development (R&D) expenses totaled ¥10,681,636.01, accounting for 44.02% of operating revenue, a decrease of 2.02 percentage points from the previous year[3][6]. - The company reported a significant increase in research and development expenses, totaling CNY 10,681,636.01 in Q1 2023, compared to CNY 9,823,271.50 in Q1 2022[18]. Future Outlook and Strategic Initiatives - The company has increased its sales efforts and is actively converting orders into performance, contributing to the revenue growth[6]. - The company is focusing on improving cash flow by enhancing the collection of accounts receivable and strengthening supply chain management[6]. - The company has not reported any significant new product developments or technological advancements during this quarter[12]. - There are no updates on market expansion or mergers and acquisitions in the current report[12]. - The company has not provided specific future guidance or performance outlook for the upcoming quarters[12]. Audit and Reporting - The financial statements for the quarter are unaudited, indicating that the figures may be subject to change upon final audit[13].